AbbVie, Investors Reach $17M Deal Over Failed Inversion
Drugmaker AbbVie Inc. has reached a $16.75 million agreement to settle a claim that it misled investors about the risks of its failed $54 billion merger with Irish pharmaceutical company Shire...To view the full article, register now.
Already a subscriber? Click here to view full article